A significant advance in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This crucial malignant protector protein is frequently disabled in many kinds of malignancies, leading https://bookmarkshq.com/story23833460/mini-antibodies-revive-the-p53-protein-new-potential-hope-for-cancer-therapy